欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/1274/001
药品名称Bortezomib PharmaSwiss
活性成分
    • BORTEZOMIB 3.5 mg
剂型Powder for solution for injection
上市许可持有人PharmaSwiss Ceská Republika, S.R.O.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Slovakia (SK)
    • Slovenia (SI)
    • Poland (PL)
      Bortezomib PharmaSwiss
    • Latvia (LV)
      Bortezomib PharmaSwiss 3,5 mg pulveris injekciju šķīduma pagatavošanai
    • Estonia (EE)
      BORTEZOMIB PHARMASWISS
    • Czechia (CZ)
      Bortezomib PharmaSwiss 3,5 mg prášek pro injekční roztok
许可日期2016/11/02
最近更新日期2021/06/18
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase